2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...
Meet Veristat in Washington D.C. at the World Vaccine Congress, 21-24 April 2025
With nearly 30 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
If your goal is to mitigate emerging threats and advance human health, you need thoughtful planning and conduct for successful clinical development. Veristat’s scientific-minded, infectious disease experts are devoted to helping you navigate this critical and challenging landscape. Our teams have led over 170 projects for infectious disease treatments and vaccines, including more than 70 COVID-19 projects.
Flexibility Comes Standard Working with Veristat
- Full-Service Solutions: End-to-end capabilities across clinical, regulatory, and post-marketing.
- Functional Services: Targeted support centered on expertise
- Strategic Resourcing: Engagement-based solutions designed to limit risk & accelerate milestonesWhether your focus is on are aiming to preventing or treating viral, bacterial, fungal, or parasitic infection, Veristat can be the difference in your study’s success. With extensive vaccine clinical trial experience and a proven ability to respond rapidly during global health crises, we are ready to help you advance with confidence.
Meet with Veristat:
Steve Jones – Senior Business Development Director
Schedule a meeting with Steve to discuss how Veristat can accelerate your vaccine program.
Learn more about the conference
5 min read
ASCO 2026: ADCs Are Redefining What Targeted Therapy Can Do
Jul 2, 2026 Veristat Blog
Antibody-drug conjugates — or ADCs — are not new. The concept of a "magic bullet" that delivers a cytotoxic payload...